Medical News

RSS

EGS announces closure of $21.5 million Series E financing

EndoGastric Solutions (EGS) today announced the closing of a $21.5 Million Series E financing. The funding will be used to support an expanding commercial presence for the company’s market-leading Natural Orifice Surgery (NOS) platform, which includes the EsophyX and StomaphyX surgical devices.

25 Nov 2009

Comparative study of antioxidant contents in chocolate and cocoa-containing products in the U.S.

A recent study confirms that the antioxidants and other plant-based nutrients in chocolate and cocoa products are highly associated with the amount of non-fat cocoa-derived ingredients in the product. The study expands on previously published results.

25 Nov 2009

Great Lakes Health Plan rated among Top 20 Medicaid health plans

Great Lakes Health Plan (GLHP), part of AmeriChoice, is rated among the nation’s Top 20 Medicaid health plans according to the 2009-10 U.S. News & World Report/National Committee for Quality Assurance (NCQA) survey of “America’s Best Health Insurance Plans.”

25 Nov 2009

Pennsylvanians at-risk for H1N1 flu receive H1N1 vaccination

Governor Edward G. Rendell today announced that 100,000 Pennsylvanians at-risk for the H1N1 flu were vaccinated during the weekend at public health clinics held by the Department of Health and local health departments.

25 Nov 2009

HKI's Shawn Baker honored for groundbreaking research on malnutrition

At two recent conferences on innovative malnutrition research organized by the Copenhagen Consensus Center, Helen Keller International's programs to reduce malnutrition were awarded first prize by government officials, NGOs, researchers and private sector representatives.

25 Nov 2009

Filing of motion to discontinue all proceedings related to patent infringement lawsuit announced

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has filed a motion to stay, or discontinue all proceedings in, the patent infringement lawsuit brought against it in October 2009 by Cook, Inc.

25 Nov 2009

NIPTE to develop educational programs on leading edge pharmaceutical technology for FDA reviewers

The U.S. Food and Drug Administration (FDA) has awarded the National Institute for Pharmaceutical Technology and Education, Inc. (NIPTE) a $652,000 two-year contract to develop and deliver a professional development program to help to ensure that FDA reviewers are current in state-of-the-art pharmaceutical manufacturing and technology.

25 Nov 2009

2010 promises to continue acquisition activity as companies seek ways to bolster their pipelines and portfolios

In the past year, drug makers' thirst for innovation combined with small companies' dwindling operating capital to drive merger and acquisition activity. At the high end of the scale, consolidation among industry leaders created some of the richest pharmaceutical mergers in history.

25 Nov 2009

Medical negligence: $22.3M for loss of left leg

A Cook County jury late yesterday awarded the parents of a now ten-year-old boy with a $22.3 million verdict in a medical negligence case arising out of the care and treatment on May 29, 1999 at Advocate Christ Medical Center/Hope Children's Hospital, in the Chicago suburb of Oak Lawn, which resulted in the loss of the boy's left leg.

25 Nov 2009

New study reveals that dentists can help detect patients with cardiovascular disease

"Dentists are really proud of their profession and feel no need to encroach upon doctors' territory," says senior dental officer and professor Mats Jontell at the Sahlgrenska Academy. "However, we wanted to find out if we as a profession could identify patients at risk of cardiovascular disease."

25 Nov 2009

Tennessee Biotechnology Association to host workshop on biotechnology industry

The Tennessee Biotechnology Association and its Graduate Alliance are jointly hosting an afternoon of biotech, business, and law on December 7th, 2009. This event will be held at Belmont University with a reception at 5pm sponsored by i3 Research.

25 Nov 2009

Evidence-based clinical research should not be influenced by political considerations, says ACP

The American College of Physicians (ACP), representing 129,000 internal medicine physicians and medical student members, believes that it is essential that research on the effectiveness and comparative effectiveness of different medical treatments not be influenced by political considerations.

25 Nov 2009

Tulane University surgeon performs a new form of endoscopic surgery

Tulane University School of Medicine surgeon Dr. Emad Kandil is one of the first in the country to perform a new form of endoscopic surgery that uses a small incision under the arm to remove all or a portion of the thyroid or parathyroid glands without leaving a scar on the neck.

25 Nov 2009

SBI urges Congress to exclude the USPSTF guidelines from health care legislation

Several sections of Senate health care reform legislation contain language stipulating that insurance entities such as private insurers, Medicare and Medicaid would only be required to cover services receiving a specific grade from the U.S. Preventative Services Task Force. Presently, this would exclude mammography services for women 40-49, would only require coverage of biennial (every other year) coverage for women 50-74, and exclude coverage for those 74 and older.

25 Nov 2009

Study may pave way for potential drug targets in lung cancer treatment

Researchers from Boston University School of Medicine (BUSM) and the Boston University Biomedical Engineering Department have identified a number of proteins whose activation allows them to distinguish between cancer and normal cells with almost 97 percent accuracy.

25 Nov 2009

Positive Phase II/III clinical data from ChemoCentryx' PROTECT-1 Traficet-EN trial

ChemoCentryx, Inc., announced today that Phase II/III clinical data from the Company's PROTECT-1 (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN(TM) (CCX282-B) in patients with moderate-to-severe Crohn's disease demonstrated clinical efficacy with a favorable safety and tolerability profile. The

25 Nov 2009

Clinical data on ImmunoGen's TAP compounds to be presented at the 51st ASH meeting

ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that presentations of clinical data for three product candidates employing its Targeted Antibody Payload (TAP) technology will be made at the 51st American Society of Hematology (ASH) Annual Meeting and Exposition to be held in New Orleans, LA, on December 5-8, 2009.

25 Nov 2009

Exercise and education program reduces disability and improves physical function after back surgery

Patients who have undergone a single-level lumbar microdiskectomy for lumbar disk herniation experienced significant improvement in physical function following an intensive, progressive physical therapist guided exercise and education program, according to a research report published in the November issue of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association (APTA).

25 Nov 2009

CHMP positive opinion for marketing ELONVA in Europe

PROLOR Biotech, Inc., today noted the positive opinion by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency for marketing approval in Europe for ELONVA(R), a long-acting CTP-modified version of the fertility hormone FSH from Merck & Co. Merck and PROLOR are both licensees of the CTP technology from Washington University in St. Louis.

25 Nov 2009

Third-quarter financial results announced by SemBioSys Genetics

SemBioSys Genetics Inc., specializing in the manufacture of high-value proteins and oils in plant seeds, today announced its third quarter 2009 financial and operational results.

25 Nov 2009

Medical News

EGS announces closure of $21.5 million Series E financing

Comparative study of antioxidant contents in chocolate and cocoa-containing products in the U.S.

Great Lakes Health Plan rated among Top 20 Medicaid health plans

Pennsylvanians at-risk for H1N1 flu receive H1N1 vaccination

HKI's Shawn Baker honored for groundbreaking research on malnutrition

Filing of motion to discontinue all proceedings related to patent infringement lawsuit announced

NIPTE to develop educational programs on leading edge pharmaceutical technology for FDA reviewers

2010 promises to continue acquisition activity as companies seek ways to bolster their pipelines and portfolios

Medical negligence: $22.3M for loss of left leg

New study reveals that dentists can help detect patients with cardiovascular disease

Tennessee Biotechnology Association to host workshop on biotechnology industry

Evidence-based clinical research should not be influenced by political considerations, says ACP

Tulane University surgeon performs a new form of endoscopic surgery

SBI urges Congress to exclude the USPSTF guidelines from health care legislation

Study may pave way for potential drug targets in lung cancer treatment

Positive Phase II/III clinical data from ChemoCentryx' PROTECT-1 Traficet-EN trial

Clinical data on ImmunoGen's TAP compounds to be presented at the 51st ASH meeting

Exercise and education program reduces disability and improves physical function after back surgery

CHMP positive opinion for marketing ELONVA in Europe

Third-quarter financial results announced by SemBioSys Genetics

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News